Haloperidol Lactate Injection, Solution
Product Images NDC 67457-426

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Haloperidol Lactate (NDC 67457-426). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mylan Institutional Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Image 01)

Chemical structure diagram of haloperidol lactate showing aromatic rings, fluorine and chlorine substituents, and functional groups consistent with the active ingredient haloperidol lactate.*

FDA Label Image

Carton (Image 02)

Packaging label for Haloperidol Injection, USP 5 mg/mL (For Immediate Release) by Mylan Institutional LLC. The label indicates it is a sterile intramuscular injection solution, packaged as 25 single-dose 1 mL vials. It includes storage instructions, preservative details, and the product NDC 67457-426-12. Manufactured in India for Mylan Institutional LLC, Morgantown, WV.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.